Pharmabiz

Thryv Therapeutics begins patient enrollment in Wave II study for Long QT Syndrome; receives US FDA fast track designation for THRV-1268

Thryv Therapeutics begins patient enrollment in Wave II study for Long QT Syndrome; receives US FDA fast track designation for THRV-1268: San Francisco Saturday, April 25, 2026, 1 ...
Pharmabiz

Philip Morris International expands its partnership with Ducati Corse as decades-long partnership races forward with purpose

Philip Morris International expands its partnership with Ducati Corse as decades-long partnership races forward with purpose: Stamford, Connecticut Saturday, April 25, 2026, 17:00 ...
Pharmabiz

Addex spin-out company Neurosterix on track to complete phase 1 study of NTX-253 for schizophrenia in Q2 2026

Addex spin-out company Neurosterix on track to complete phase 1 study of NTX-253 for schizophrenia in Q2 2026: Geneva, Switzerland Saturday, April 25, 2026, 14:00 Hrs [IST] Addex ...
Pharmabiz

Regeneron inks agreement with US government to help lower drug costs for American patients and will provide innovative new gene therapy for free in the US

Regeneron inks agreement with US government to help lower drug costs for American patients and will provide innovative new gene therapy for free in the US: Tarrytown, New York Sat ...
Pharmabiz

Worldwide Clinical Trials, Medidata partner to embed Medidata AI across the full clinical trial lifecycle; bolsters study execution and delivery excellence

Worldwide Clinical Trials, Medidata partner to embed Medidata AI across the full clinical trial lifecycle; bolsters study execution and delivery excellence: Research Triangle Park ...
Pharmabiz

GE HealthCare doses first patient in phase 2/3 LUMINA trial for manganese-based MRI contrast agent, mangaciclanol

GE HealthCare doses first patient in phase 2/3 LUMINA trial for manganese-based MRI contrast agent, mangaciclanol: Chalfont St Giles,?UK Saturday, April 25, 2026, 12:00 Hrs [IST] ...
Pharmabiz

Novartis malaria treatment Coartem Baby receives WHO prequalification, paving way for greater access for newborns and young infants

Novartis malaria treatment Coartem Baby receives WHO prequalification, paving way for greater access for newborns and young infants: Basel Saturday, April 25, 2026, 09:00 Hrs [IST ...
Pharmabiz

CMS & US FDA announce RAPID coverage pathway to accelerate patient access to life-changing medical devices

CMS & US FDA announce RAPID coverage pathway to accelerate patient access to life-changing medical devices: Maryland Saturday, April 25, 2026, 11:00 Hrs [IST] The Centers for Medi ...
Pharmabiz

NCCN announces awards for improvement initiatives for chronic myeloid leukaemia

NCCN announces awards for improvement initiatives for chronic myeloid leukaemia: Plymouth Meeting, Pennsylvania Saturday, April 25, 2026, 10:00 Hrs [IST] The National Comprehensiv ...
Pharmabiz

WHO reports measurable health impact in 2025 amid transition to new strategy

WHO reports measurable health impact in 2025 amid transition to new strategy: Geneva Saturday, April 25, 2026, 15:00 Hrs [IST] The World Health Organization (WHO) released its Res ...
Pharmabiz

Indian pharma steps up innovation push, expands focus beyond generics to new therapeutic discoveries

Indian pharma steps up innovation push, expands focus beyond generics to new therapeutic discoveries: Nandita Vijayasimha, Bengaluru Saturday, April 25, 2026, 08:00 Hrs [IST] Indi ...
Pharmabiz

IPC leads scientific conclave to advance IP 2026 Standards on weights, balances & pH

IPC leads scientific conclave to advance IP 2026 Standards on weights, balances & pH: Shardul Nautiyal, Mumbai Saturday, April 25, 2026, 08:00 Hrs [IST] In a significant step towa ...